Salute e Benessere

L'OCCITANE Launches Ecosystem Restoration Fund

Alongside these ongoing efforts, L'OCCITANE seeks to be able to respond to environmental disasters as they unfold. The Group has pledged to set up a support fund of €400,000 to help finance long-lasting projects dedicated to the regeneration of severely damaged ecosystems. €200,000 will be donated as an immediate contribution to tree-planting and agroforestry schemes to help restore Australia's landscape over the next 10 years. The projects will be carefully chosen by the L'OCCITANE Foundation,…
PR Newswire
19/01/2020 18:00

Sanofi: information concerning the total number of voting rights and shares,…

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,504,039,842 € Registered office : 54, rue La Boétie – 75008 Paris – France Registered at the Paris Commercial and...
Nasdaq GlobeNewswire
17/01/2020 18:00

Women's HealthCare Market Worth $17.8 Billion by 2024 - Exclusive Report by…

The Women's Health Care Market growth is largely driven by the growing incidence of chronic health conditions among women, government initiatives to curb population growth, growing demand for contraceptives to prevent unintended pregnancies, and the growing focus on R&D by key players for the development of advanced products. On the other hand, the reluctance to use contraceptives is a major factor limiting the Women's HealthCare Market growth. The Women's Health Care Market growth is…
PR Newswire
17/01/2020 15:30

Flow Cytometry Market Worth $6.4 Billion by 2025 - Exclusive Report by…

The major factors driving the growth of the Flow Cytometry Market are the technological advancements in flow cytometers, increasing adoption of flow cytometry techniques in research activities & clinical trials, the growing focus on immunology and immuno-oncology research, increasing incorporation of AI platforms in flow cytometry workflows & advancements in flow cytometry software, high incidence and prevalence of HIV-AIDS & cancer, and availability of novel application-specific…
PR Newswire
17/01/2020 14:30

Holding(s) in Company TR-1: Standard form for notification of major holdings

TR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuerandto the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Verona Pharma plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuer 2. Reason for the notification(please...
Nasdaq GlobeNewswire
17/01/2020 14:06

Philips partners with the United Nations Population Fund and the Government of…

A comprehensive 'Emergency obstetric and newborn care' (EmONC) program will be implemented in healthcare facilities in underserved communities in the Republic of the Congo The agreement is a tangible local milestone of the global partnership between Philips and UNFPA aimed at improving the health and well-being of fifty (50) million women and girls in countries where health challenges are greatest, launched in 2019 Amsterdam, The Netherlands– Royal Philips (NYSE: PHG; AEX:...
Nasdaq GlobeNewswire
17/01/2020 13:00

Veterinary CRO Market to Reach $1.33 Bn, Globally, by 2026 at 8.1% CAGR, Says…

Incentives for market growth Incentives for market growth Rise in ownership of companion animals, increase in animal health expenditure, and surge in prevalence of various diseases among companion animals have boosted the growth of the global veterinary CRO market. However, lack of standardization in veterinary CROs hamper the market growth. On the contrary, rise in awareness regarding animal healthcare is expected to create lucrative opportunities in the near future. Request Sample...
PR Newswire
17/01/2020 10:00

SKF's Year-end Results to be Published on 4 February 2020

To join the conference call, please dial-in at least 10 minutes before the start of the call using the following details: To join the conference call, please dial-in at least 10 minutes before the start of the call using the following details: International: +44(0)2071-928000 Sweden : +46(0)8-5069-2180 United States : +1-631-510-7495 The conference ID for the call is either SKF or 3662219. All information regarding the results will be made available on the Group's website:...
PR Newswire
17/01/2020 08:50

Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary…

Company Release no. 6/2020To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 17 January 2020Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary PublicTender OfferAsahi Kasei Pharma Denmark A/S, which on 15 January 2020 announced the preliminary result of the voluntary public tender offer for the shares and warrants in Veloxis Pharmaceuticals A/S, today announces the final result of the voluntary public...
Nasdaq GlobeNewswire
17/01/2020 08:01

Clarivate Analytics to Acquire Decision Resources Group, Creating a Leading…

Jerre Stead, Executive Chairman and CEO, Clarivate Analytics: "This is a milestone acquisition which doubles the size of our Life Sciences business, is accretive to our 2020 earnings, and sets us up to become an essential, end-to-end, industry-leading data and analytics provider to the highly attractive Life Sciences ecosystem. We expect the acquisition of DRG to increase Clarivate's total company revenue by 20%, deliver approximately $77 million in annual Adjusted EBITDA before the pursuit…
PR Newswire
17/01/2020 08:00

Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes…

Rybelsus ®label updated with additional information from the PIONEER 6 CV outcomes trialBagsværd, Denmark, 16 January 2020 –Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion based on a supplemental New Drug Application (sNDA) for Ozempic ®(once-weekly semaglutide) for the indication of reducing the risk of major adverse cardiovascular events (MACE) including cardiovascular death, non-fatal heart attack, or non-fatal...
Nasdaq GlobeNewswire
16/01/2020 23:38

SPINEWAY - 2019 : A year of restructuring - 2019 revenue of €5M

SPINEWAY 2019: a year of restructuring 2019 revenue of €5M 2019 was a particularly active year for the SPINEWAY group as it redeployed its activities in previously covered areas, completely reorganized its teams and renewed half its Executive Committee at the end of 2019. Spineway also strengthened its financial position thanks to a financing agreement with Negma Group 1 in order to ensure organic growth and finance new development projects. The Group thus generated total...
Nasdaq GlobeNewswire
16/01/2020 18:00

Kat Von D Departs + Sells Ownership Shares Of Kat Von D Beauty To Pursue Vegan…

SAN FRANCISCO, Jan. 16, 2020 /PRNewswire/ -- Kat Von D Beauty announced today that founder Kat Von D has made a full departure from the brand to focus on other artistic endeavors (namely, her vegan shoe line and upcoming album), thus making KENDO the sole owner and force behind the beauty line. Effective immediately, the brand will now be called KVD Vegan Beauty. SAN FRANCISCO,Jan. 16, 2020/PRNewswire/ -- Kat Von D Beauty announced today that founder Kat Von D has made a full departure...
PR Newswire
16/01/2020 18:00

Press release - Q4 2019 Sales

2019 NET SALESFull-year 2019 net sales of €34.6bn 1, up +4.2% 2organically and +2.2% 2on a same-store basisQ4 2019 net sales of €9.2bn 1, up +3.6% 2on an organic basis and +1.6% 2on a same-store basis. In France, stable same-store net sales, strong organic growth in Latam (+9.2%) Business reorganisation in Latin AmericaHighlights In France, the main new highlight of the Q4 2019 and beginning 2020 is the strong increase in customer traffic driven by the fast...
Nasdaq GlobeNewswire
16/01/2020 17:49

Virbac: 2019 annual revenue shows strong growth of +6.6% at constant exchange…

2019 annual revenue shows strong growth of +6.6% at constant exchange rates KEY FIGURES Revenue in 2019 Provisional €938.2 millionTotal growth +8.0%Growth at constant exchange rates +6.6%Growth at constant exchange rates and scope1 +6.6% of whichcompanion animals +9.5% production animals +2.4% 1Growth at constant exchange rates and scope represents the organic growth in sales excluding variations in exchange...
Nasdaq GlobeNewswire
16/01/2020 17:45

Isothermal Nucleic Acid Amplification Technology Market Worth $3.3 Billion in…

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=839 https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=839 The Factors such as the rising prevalence of infectious diseases and the introduction of newer pathogens, the need for prompt diagnosis, the increasing number of blood transfusions and donations, and the cost-benefits of INAAT are the key factors driving the market growth. Assay, kits and reagents segment to account for the largest share of the global INAAT Market...
PR Newswire
16/01/2020 16:30

How Dying Cells Prevent Dangerous Immune Reactions - New Receptor for Treatment…

Dying cells in the body can keep the immune system in check, thus preventing unwanted immune responses against the body's own tissues. Scientists from the German Cancer Research Center have now identified a receptor on murine immune cells that activates this protective mechanism and can thus prevent dangerous autoimmune reactions in which the immune system attacks the patient's own body tissues. Dying cells in the body can keep the immune system in check, thus preventing unwanted immune...
PR Newswire
16/01/2020 15:51

Signant Health Finds Growing eConsent Adoption Forecasts and the Importance of…

Signant Health began surveying those involved in the delivery of eConsent in 2017, releasing their findings to the industry in order to support the adoption of eConsent globally. Understanding the features of solutions that most impact the improvement of patient comprehension and patient and site experience helps to focus ongoing development of these solutions at Signant Health. Signant Health began surveying those involved in the delivery of eConsent in 2017, releasing their findings to the...
PR Newswire
16/01/2020 15:35

Immunosuppressant Market to Reach $42.51 Bn, Globally, by 2026 at 14.7% CAGR:…

Drivers, restraints, and opportunities- Drivers, restraints, and opportunities- Increase in autoimmune disorders, and surge in demand for organ transplantation drive the growth of the global immunosuppressant market. On the other hand, lack of awareness toward organ transplantation impedes the growth to certain extent. However, several growth prospects in emerging economies have created a number of opportunities for the key players in the industry. Request Sample Report at: ...
PR Newswire
16/01/2020 15:30

How Dying Cells Prevent Dangerous Immune Reactions - New Receptor for Treatment…

Dying cells in the body can keep the immune system in check, thus preventing unwanted immune responses against the body's own tissues. Scientists from the German Cancer Research Center have now identified a receptor on murine immune cells that activates this protective mechanism and can thus prevent dangerous autoimmune reactions in which the immune system attacks the patient's own body tissues. Dying cells in the body can keep the immune system in check, thus preventing unwanted immune...
PR Newswire
16/01/2020 15:29

Snap Fitness Poised for Continued International Expansion in 2020

Snap Fitness celebrates the new year with its 100th club opening in Europe and the launch of a new state-of-the-art club design with bespoke lighting and the latest fitness technology in the United Kingdom and Ireland. Additional key markets for expansion in 2020 include Australia, New Zealand, Mexico, Turkey and the United Arab Emirates. Snap Fitness celebrates the new year with its 100th club opening inEuropeand the launch of a new state-of-the-art club design with bespoke lighting and...
PR Newswire
16/01/2020 15:15

New Study Indicates 'Helper' Cells May Kill Cancerous Tumors

Companies across the biotech space continue to seek new and novel therapies to screen for and treat a wide variety of blood borne cancers. New information in the space is key to providing links between drug therapies and strategies. Companies in this space are expecting to see significant increases in revenue and support for new technologies supported by leaders in the sector including Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), and…
PR Newswire
16/01/2020 15:00